Article Information
History
- February 26, 2022.
Article Versions
- Version 1 (January 24, 2022 - 17:39).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Suchitra Kamle1,
- Bing Ma1,
- Chang Min Lee1,
- Gail Schor1,
- Yang Zhou1,
- Chun Geun Lee1 and
- Jack A. Elias1,2,#
- 1Molecular Microbiology and Immunology, Brown University 185 Meeting St. Providence, RI. 02912, USA
- 2Department of Medicine Brown University Providence, RI 02912, USA
- ↵#corresponding author: jack_elias{at}brown.edu
Author Contributions Conception and design: SK, JAE, CGL; Generation of experimental resources and data collection: SK, BM, CML, GS, YZ; Analysis and interpretation: SK, CGL, JAE; Drafting the manuscript for important intellectual content: JAE, CGL, SK.
Posted February 26, 2022.
Host Chitinase 3-like-1 is a Universal Therapeutic Target for SARS-CoV-2 Viral Variants in COVID 19
